HealthEquity, Inc. (NASDAQ:HQY) Stock Rated “Moderate Buy” by Wall Street Analysts

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been given a consensus rating of “Moderate Buy” by the thirteen brokerages that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, ten have issued a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $112.20.

Several equities analysts have recently weighed in on HQY shares. Raymond James Financial reaffirmed a “strong-buy” rating on shares of HealthEquity in a report on Thursday, September 3rd. Citigroup reissued a “market outperform” rating on shares of HealthEquity in a report on Friday, August 28th. Deutsche Bank Aktiengesellschaft raised their price target on shares of HealthEquity from $135.00 to $142.00 and gave the company a “buy” rating in a research report on Monday, August 31st. Barclays raised their price target on shares of HealthEquity from $110.00 to $115.00 and gave the company an “overweight” rating in a research report on Friday, September 18th. Finally, Weiss Ratings cut shares of HealthEquity from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 2nd.

HealthEquity Stock Performance

Shares of HQY stock traded down $0.48 during trading hours on Friday, hitting $92.03. The company’s stock had a trading volume of 550,683 shares, compared to its average volume of 911,772. The company has a 50 day moving average of $96.08 and a 200 day moving average of $91.40. The stock has a market cap of $7.61 billion, a PE ratio of 33.22, a price-to-earnings-growth ratio of 1.46 and a beta of 0.24. The company has a current ratio of 2.99, a quick ratio of 2.99 and a debt-to-equity ratio of 0.47. HealthEquity has a 12-month low of $72.76 and a 12-month high of $107.62.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Thursday, August 27th. The company reported $1.24 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.05. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. The business had revenue of $350.73 million during the quarter, compared to analyst estimates of $349.22 million. The company’s revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. On average, sell-side analysts forecast that HealthEquity will post 3.93 EPS for the current fiscal year.

Insider Activity

In other news, Director Adrian Dillon sold 7,632 shares of the firm’s stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total transaction of $798,383.52. Following the sale, the director directly owned 62,395 shares in the company, valued at $6,527,140.95. This trade represents a 10.90% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.60% of the stock is currently owned by insiders.

Hedge Funds Weigh In On HealthEquity

A number of large investors have recently bought and sold shares of HQY. Oxbow Advisors LLC acquired a new position in shares of HealthEquity during the 1st quarter worth approximately $3,147,000. Maridea Wealth Management LLC purchased a new position in shares of HealthEquity during the 2nd quarter valued at approximately $2,753,000. Amundi lifted its position in shares of HealthEquity by 33.6% during the 2nd quarter. Amundi now owns 90,327 shares of the company’s stock valued at $8,158,000 after buying an additional 22,735 shares in the last quarter. Deutsche Bank AG acquired a new stake in HealthEquity in the 2nd quarter valued at $11,986,000. Finally, Bamco Inc. NY acquired a new stake in HealthEquity in the 2nd quarter valued at $67,776,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) provides technology-enabled services for consumer-directed health and benefits accounts. The company administers health savings accounts (HSAs) and offers related products such as flexible spending accounts, health reimbursement arrangements, commuter benefits and other employee benefit programs.

Its platform is designed to help employers, benefits advisors, health plans and individuals manage benefits, make healthcare payments, access account information and invest eligible HSA funds.